Technical Analysis for NONOF - Novo Nordisk A/S

Grade Last Price % Change Price Change
grade B 48.08 3.49% 1.6200
NONOF closed up 3.49 percent on Wednesday, May 22, 2019, on 9 percent of normal volume. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Up
See historical NONOF trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Crossed Above 200 DMA Bullish 0.00%
Stochastic Buy Signal Bullish 0.00%
Doji - Bearish? Reversal 0.00%
Gapped Up Strength 0.00%
Oversold Stochastic Weakness 0.00%
Slingshot Bearish Bearish Swing Setup 3.49%
Narrow Range Bar Range Contraction 3.49%
Gapped Up Strength 3.49%
Oversold Stochastic Weakness 3.49%

Older signals for NONOF ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Novo-Nordisk is the parent company of a group engaged in the development, production and marketing of pharmaceuticals, biological solutions to industrial problems; vitamins, dietary supplements and digestive aids. Co. operates on a worldwide basis in two business segments: Diabetes care: discovery, development, manufacturing and marketing of products within the areas of insulin and delivery systems and oral antidiabetic products (OAD). Biopharmaceuticals: discovery, development, manufacturing and marketing of products within the therapy areas haemostasis management (NovoSeven?), growth hormone therapy, hormone replacement therapy and other products.
Medicine Health Manufacturing RTT Pharmaceuticals Pharmaceutical Industry Biopharmaceutical Pharmacy Diabetes Dietary Supplements Endocrine System Biopharmaceuticals Peptide Hormones Insulin Diabetes Care Growth Hormone Therapy Recombinant Proteins Biological Solutions Growth Hormone Hormone Replacement Therapy Hormone Therapy
Is NONOF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 58.0
52 Week Low 40.99
Average Volume 38,167
200-Day Moving Average 47.3652
50-Day Moving Average 49.4446
20-Day Moving Average 48.159
10-Day Moving Average 47.551
Average True Range 0.8666
ADX 15.53
+DI 43.0885
-DI 42.7704
Chandelier Exit (Long, 3 ATRs ) 48.0002
Chandelier Exit (Short, 3 ATRs ) 48.8898
Upper Bollinger Band 50.3297
Lower Bollinger Band 45.9883
Percent B (%b) 0.48
BandWidth 9.014722
MACD Line -0.7026
MACD Signal Line -0.6039
MACD Histogram -0.0987
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 49.1600
Resistance 3 (R3) 49.0733 48.6267 48.9800
Resistance 2 (R2) 48.6267 48.3516 48.6700 48.9200
Resistance 1 (R1) 48.3533 48.1817 48.4900 48.4400 48.8600
Pivot Point 47.9067 47.9067 47.9750 47.9500 47.9067
Support 1 (S1) 47.6333 47.6316 47.7700 47.7200 47.3000
Support 2 (S2) 47.1867 47.4617 47.2300 47.2400
Support 3 (S3) 46.9133 47.1867 47.1800
Support 4 (S4) 47.0000